Moreover, the mucosa of patients with established Crohn's disease are dominated by CD4+ T lymphocytes, which are distinguished by their capacity for producing interferon-γ (IFN-γ) and interleukin-2 (IL-2) [3], [4], [5]. This evidence concerns the gene IL2 and Crohn disease.